Acute myeloid leukemia driven by tandem duplications within the UBTF gene (UBTF-TD AML) is a high-risk pediatric cancer in urgent need of novel therapeutic options. To better understand this disease and how to treat it, St. Jude Children’s Research Hospital scientists studied what was causing UBTF-TD to behave abnormally.
This article was originally published on MedicalXpress.com

